Citadel Advisors
ZURA icon

Citadel Advisors’s Zura Bio ZURA Stock Holding History

Citadel Advisors’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Sell
17,898
-291,259
-94% -$1.76M ﹤0.01% 11960
2025
Q4 		$1.62M Buy
309,157
+228,629
+284% +$904K ﹤0.01% 6340
2025
Q3 		$349K Buy
+80,528
New +$145K ﹤0.01% 10011
2025
Q1 		– Sell
-57,779
Closed -$91.1K – 15736
2024
Q4 		$144K Sell
57,779
-279,049
-83% -$994K ﹤0.01% 10945
2024
Q3 		$1.37M Sell
336,828
-296,835
-47% -$1.11M ﹤0.01% 6235
2024
Q2 		$2.22M Sell
633,663
-47,757
-7% -$195K ﹤0.01% 5122
2024
Q1 		$1.75M Sell
681,420
-11,374
-2% -$40.3K ﹤0.01% 5786
2023
Q4 		$3.24M Sell
692,794
-19,706
-3% -$98.5K ﹤0.01% 4517
2023
Q3 		$4.7M Sell
712,500
-405
-0.1% -$2.71K ﹤0.01% 3747
2023
Q2 		$5.55M Buy
+712,905
New +$5.73M ﹤0.01% 3490

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Citadel Advisors's ZURA Position: Q1 2026 in Review

Citadel Advisors reduced its Zura Bio (ZURA) stake by 94% in Q1 2026, selling an estimated $1.76M and leaving 17,898 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #11960.

Citadel Advisors first reported a position in ZURA in Q2 2023 and has held it in 10 quarters since. The position peaked at $5.55M in Q2 2023. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Citadel Advisors held 17,898 shares of Zura Bio worth $106K as of Q1 2026.
  • Citadel Advisors sold 291,259 Zura Bio shares in Q1 2026, an estimated $1.76M.
  • Zura Bio made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11960 holding.
  • Citadel Advisors first reported a position in Zura Bio in Q2 2023 and has held it in 10 quarters since.
  • Citadel Advisors's Zura Bio position peaked at $5.55M in Q2 2023.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.